Results
|
61.
|
The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance. [electronic resource] by
- Barbone, D
- Ryan, J A
- Kolhatkar, N
- Chacko, A D
- Jablons, D M
- Sugarbaker, D J
- Bueno, R
- Letai, A G
- Coussens, L M
- Fennell, D A
- Broaddus, V C
Producer: 20120301
In:
Cell death & disease vol. 2
Availability: No items available.
|
|
62.
|
Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo. [electronic resource] by
- Manente, A G
- Valenti, D
- Pinton, G
- Jithesh, P V
- Daga, A
- Rossi, L
- Gray, S G
- O'Byrne, K J
- Fennell, D A
- Vacca, R A
- Nilsson, S
- Mutti, L
- Moro, L
Producer: 20130924
In:
Oncogenesis vol. 2
Availability: No items available.
|
|
63.
|
Resistance to HSP90 inhibition involving loss of MCL1 addiction. [electronic resource] by
- Busacca, S
- Law, E W P
- Powley, I R
- Proia, D A
- Sequeira, M
- Le Quesne, J
- Klabatsa, A
- Edwards, J M
- Matchett, K B
- Luo, J L
- Pringle, J H
- El-Tanani, M
- MacFarlane, M
- Fennell, D A
Producer: 20160808
In:
Oncogene vol. 35
Availability: No items available.
|
|
64.
|
Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly. [electronic resource] by
- Majkut, J
- Sgobba, M
- Holohan, C
- Crawford, N
- Logan, A E
- Kerr, E
- Higgins, C A
- Redmond, K L
- Riley, J S
- Stasik, I
- Fennell, D A
- Van Schaeybroeck, S
- Haider, S
- Johnston, P G
- Haigh, D
- Longley, D B
Producer: 20151102
In:
Nature communications vol. 5
Availability: No items available.
|
|
65.
|
Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer. [electronic resource] by
- Riley, J S
- Hutchinson, R
- McArt, D G
- Crawford, N
- Holohan, C
- Paul, I
- Van Schaeybroeck, S
- Salto-Tellez, M
- Johnston, P G
- Fennell, D A
- Gately, K
- O'Byrne, K
- Cummins, R
- Kay, E
- Hamilton, P
- Stasik, I
- Longley, D B
Producer: 20140612
In:
Cell death & disease vol. 4
Availability: No items available.
|
|
66.
|
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1). [electronic resource] by
- Ramalingam, S
- Goss, G
- Rosell, R
- Schmid-Bindert, G
- Zaric, B
- Andric, Z
- Bondarenko, I
- Komov, D
- Ceric, T
- Khuri, F
- Samarzija, M
- Felip, E
- Ciuleanu, T
- Hirsh, V
- Wehler, T
- Spicer, J
- Salgia, R
- Shapiro, G
- Sheldon, E
- Teofilovici, F
- Vukovic, V
- Fennell, D
Producer: 20160421
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|